Home > Publications Database > Efficacy and cost-effectiveness of extended nursing roles in dementia care: Results of the cluster-randomized trial InDePendent. > print

001     281827
005     20251113125814.0
024 7 _ |a 10.1002/alz.70727
|2 doi
024 7 _ |a pmid:41143334
|2 pmid
024 7 _ |a pmc:PMC12556587
|2 pmc
024 7 _ |a 1552-5260
|2 ISSN
024 7 _ |a 1552-5279
|2 ISSN
037 _ _ |a DZNE-2025-01208
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Rädke, Anika
|0 P:(DE-2719)9001134
|b 0
|e First author
|u dzne
245 _ _ |a Efficacy and cost-effectiveness of extended nursing roles in dementia care: Results of the cluster-randomized trial InDePendent.
260 _ _ |a Hoboken, NJ
|c 2025
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1763034736_32673
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Extended nursing roles in dementia can improve treatment, care, and patient and caregiver outcomes. We tested the efficacy and cost-effectiveness in people living with dementia (PlwD) and caregivers.We analyzed data from 417 PlwD within the multicenter, cluster-randomized InDePendent trial six months after baseline. Specifically, qualified nurses carried out advanced dementia care management individually tailored to each patient's and caregiver's needs. Outcomes included unmet needs (CANE), quality of life (QoL-AD, EQ-5D), caregiver burden (Zarit), and cost-effectiveness (FIMA, RUD).PlwD receiving the intervention had 74% lower unmet needs (0.26, CI95%: 0.17 to 0.40, p < 0.001) and higher quality of life (0.04, CI95%: 0.01 to 0.07, p = 0.017) than controls. There was a gain in quality-adjusted life years (0.01, CI95%: -0.001 to 0.018) at slightly higher costs (1,425 EUR, CI95%: 638 to 2,211). There was no effect on caregiver burden after six months.The results provide evidence for the efficacy and cost-effectiveness of extended nursing roles in dementia care, demonstrating that extended nursing roles reduce unmet needs and improve quality of life.This trial was prospectively registered on ClinicalTrials.gov under the identifier NCT04741932 on February 2, 2021.The InDePendent intervention significantly reduced the number of unmet needs in PlwD and their caregiver according to CANE. Extended nursing roles can improve PlwD's health-related Quality of Life. Advanced dementia care management were likely to be cost-effective after six months.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a advanced nursing
|2 Other
650 _ 7 |a cost‐effectiveness
|2 Other
650 _ 7 |a dementia
|2 Other
650 _ 7 |a primary care
|2 Other
650 _ 7 |a randomized controlled trial
|2 Other
650 _ 7 |a unmet needs
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Dementia: nursing
|2 MeSH
650 _ 2 |a Dementia: economics
|2 MeSH
650 _ 2 |a Cost-Benefit Analysis
|2 MeSH
650 _ 2 |a Caregivers: psychology
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Quality of Life
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Nurse's Role
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
650 _ 2 |a Quality-Adjusted Life Years
|2 MeSH
700 1 _ |a Michalowsky, Bernhard
|0 P:(DE-2719)2810763
|b 1
|u dzne
700 1 _ |a Kleinke, Fabian
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Platen, Moritz
|0 P:(DE-2719)9001238
|b 3
|u dzne
700 1 _ |a Scharf, Annelie
|0 P:(DE-2719)9001251
|b 4
|u dzne
700 1 _ |a Pfaff, Michelle
|0 P:(DE-2719)9002113
|b 5
|u dzne
700 1 _ |a Buchholz, Maresa
|0 P:(DE-2719)9002138
|b 6
|u dzne
700 1 _ |a Mühlichen, Franka
|0 P:(DE-2719)9001235
|b 7
|u dzne
700 1 _ |a Penndorf, Peter
|b 8
700 1 _ |a Schade, Stefanie
|b 9
700 1 _ |a Dombrowski, Janina
|b 10
700 1 _ |a Lerch, Pia Elisa Madaida
|b 11
700 1 _ |a Reber, Katrin Christiane
|b 12
700 1 _ |a Austenat-Wied, Manon
|b 13
700 1 _ |a Martens, Cornelia
|b 14
700 1 _ |a van den Berg, Neeltje
|b 15
700 1 _ |a Hoffmann, Wolfgang
|0 P:(DE-2719)2000040
|b 16
|e Last author
|u dzne
773 _ _ |a 10.1002/alz.70727
|g Vol. 21, no. 10, p. e70727
|0 PERI:(DE-600)2201940-6
|n 10
|p e70727
|t Alzheimer's and dementia
|v 21
|y 2025
|x 1552-5260
856 4 _ |u https://pub.dzne.de/record/281827/files/DZNE-2025-01208%20SUP.zip
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/281827/files/DZNE-2025-01208.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/281827/files/DZNE-2025-01208.pdf?subformat=pdfa
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9001134
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2810763
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9001238
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)9001251
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)9002113
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)9002138
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)9001235
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 16
|6 P:(DE-2719)2000040
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-06
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2025-01-06
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2025-01-06
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-06
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-06
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-06
920 1 _ |0 I:(DE-2719)1510600
|k AG Hoffmann
|l Translational Health Care Research
|x 0
920 1 _ |0 I:(DE-2719)5000067
|k AG Michalowsky
|l Patient-Reported Outcomes and Health Economics Research
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1510600
980 _ _ |a I:(DE-2719)5000067
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21